Fellows4Fungi · Exploring fungal pathogens within unexplored microbial networks
Horizon Europe — Marie Skłodowska-Curie Actions
- Duration
- 2026-08-01 → 2031-07-31
- EU contribution
- €2,030,400
- Participants
- 19
- Scheme
- HORIZON-TMA-MSCA-Cofund-P
Lines connect the coordinator with its partners.
Project objective
Fellows4Fungi is a prestigious international postdoctoral programme addressing the urgent global health challenge of fungal infections. Hosted by the Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute (LEIBNIZ-HKI) in Jena, Germany, the programme will recruit 12 top-tier researchers through two calls, offering 36-month fellowships that combine research freedom with structured, interdisciplinary training.LEIBNIZ-HKI is Germany’s only academic centre dedicated to human-pathogenic fungi and a global leader in antifungal research and natural product discovery. Fellows will carry out pioneering work across six strategic research areas, ranging from AI-driven drug discovery and fungal pathogenesis to microbiome modelling and epigenetics. The programme’s scientific mission directly addresses the World Health Organization’s (WHO) call to action on fungal pathogens such as Aspergillus fumigatus and Candida albicans, which are rising in clinical relevance due to increasing antifungal resistance.Fellows4Fungi offers access to cutting-edge infrastructure – including robotics platforms, high-performance computing, and a unique microbial strain collection -alongside secondments and mentoring with 18 leading academic, clinical, and biotech partners in 7 countries. The programme combines scientific excellence with a strong commitment to open science, equality, and responsible research, supporting fellows with competitive salaries, personalised career development, and an inclusive research environment. Fellows4Fungi will train the next generation of leaders to bridge innovation gaps and drive advances in antifungal therapy, diagnostics, and data-driven healthcare solutions.
Original text from CORDIS.
Participants
- LEIBNIZ-INSTITUT FUR NATURSTOFF-FORSCHUNG UND INFEKTIONSBIOLOGIE EV HANS-KNOLL-INSTITUT · JENACoordinatorGermany
- ALTONA DIAGNOSTICS GMBH · HamburgGermany
- ASCENION GmbH · MunichGermany
- Analytik Jena Gmbh+Co.KG · JenaGermany
- BIOFACTION KG · WienAustria
- BIOMARKER TECHNOLOGIES (BMK) GMBH · MUNSTERGermany
- Bright Giant GmbH · JenaGermany
- DANMARKS TEKNISKE UNIVERSITET · Kongens LyngbyDenmark
- E1 DATASCIENCE LTD · BEDFORDUnited Kingdom
- ELLINIKOS GEORGIKOS ORGANISMOS - DIMITRA · ATHINAGreece
- FRIEDRICH LOEFFLER INSTITUT - BUNDESFORSCHUNGSINSTITUT FUER TIERGESUNDHEIT · Greifswald-Insel RiemsGermany
- FRIEDRICH-SCHILLER-UNIVERSITÄT JENA · JENAGermany
- HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH · BraunschweigGermany
- JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG · WuerzburgGermany
- NOVOGENE NETHERLANDS BV · AmsterdamNetherlands
- PERSEUS BIOMICS · TienenBelgium
- ROBERT KOCH-INSTITUT · BerlinGermany
- SmartDyeLivery GmbH · JenaGermany
- UNIVERSITY OF STUTTGART · StuttgartGermany
Links
Data: CORDIS, © European Union